Business

Rethinking care after an ALS . diagnosis

Hemant Taneja, a managing partner at venture capital firm General Catalyst, one of Livongo’s early investors, “creates the belief that you can build these types of companies.

Investors have taken note, pouring money into so-called health tech deals. American investors invested about $32 billion in private healthcare technology companies last year, a record number and nearly double that of 2020, according to PitchBook data.

Dr. Krishna Yeshwant, a managing partner at GV who is leading the Synapticure investment, got to know the company through a colleague, Graham Spencer, who has ALS. Others at GV sought to help their colleagues, he said the company wouldn’t invest in Synapticure unless it was a clear opportunity for big profits.

“It can cost you a lot of money to solve complicated problems for your friends,” says Dr. Yeshwant.

Synapticure makes as much money as a typical doctor’s office does, charging insurance companies for their services, including counseling and neurosurgery. It does not collect any additional fees for the patient.

The company’s nurses, counselors, neurologists, and medical assistants help patients sort through their existing care and connect them to providers who can fill any gaps. which blank. The company also tracks current and pending clinical trials to see which of its users might be eligible. With a database of customers eager to share their health records, Synapticure hopes to make it easier for biotech startups conducting these tests to find research subjects. potential, an expensive and time consuming endeavor.

“It’s a clear need,” said Dr. Eva Feldman, director of the ALS Center of Excellence at the University of Michigan. She and her team spend about four hours with each patient during each visit — the maximum amount of time they can handle — leaving no time to talk about outside research.

“Right now we’re just discussing the clinical trials we’re doing, and that’s what every center does,” said Dr. Feldman.

https://www.nytimes.com/2022/02/01/business/als-synapticure-startup.html Rethinking care after an ALS . diagnosis

Fry Electronics Team

Fry Electronics.com is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@fry-electronics.com. The content will be deleted within 24 hours.

Related Articles

Back to top button